# Bioavailability Study of Torsemide Tablets Under Fed Conditions

> **NCT00654043** · PHASE1 · COMPLETED · sponsor: **Par Pharmaceutical, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Torsemide
- **DRUG:** Demadex

## Key facts

- **NCT ID:** NCT00654043
- **Lead sponsor:** Par Pharmaceutical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2001-05
- **Final completion:** 2001-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2008-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00654043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00654043, "Bioavailability Study of Torsemide Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00654043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*